Severe Lead Poisoning Managed with Combination Chelation Therapy: Report from a Resource-limited Country
Journal of The Association of Physicians of India · 2025
DOI: 10.59556/japi.73.0806 ↗At a glance
Fallbericht in Journal of The Association of Physicians of India, 2025. Written by Omender Singh and 3 co-authors. Institution: Principal Director, Institute of Critical Care Medicine, Max Super Speciality Hospital, New Delhi, Delhi, India. Major MEDLINE topics: Lead Poisoning, Chelating Agents, Chelation Therapy, Penicillamine. Cited 1 times so far (Crossref); 9 references.
Abstract (original language)
BACKGROUND: An increasing number of cases of lead toxicity are being reported among patients taking Ayurvedic and other alternative medicines. These medicines may have varying amounts of heavy metals, making the diagnosis confusing and treatment challenging. The unavailability of certain chelating agents in resource-poor settings limits therapeutic options. CASE DESCRIPTION: A 38-year-old, recently diagnosed diabetic male, presented with complaints of vomiting, abdominal pain, and constipation. There was a history of consumption of Ayurvedic medications and other herbal supplements for the past 2 months. Serum lead levels were 120 µg/dL, for which intramuscular dimercaprol was initiated. Other heavy metals, selenium, nickel, and zinc, were also in the higher range. Due to worsening neurological symptoms and unavailability of calcium disodium edetate (CaNa2EDTA), D-penicillamine was added to the therapy. Clinical improvement was noted, but D-penicillamine was replaced with CaNa2EDTA after a few days, when it became available. The patient was discharged from the hospital with no neurological sequelae. CONCLUSION: Lead poisoning should be suspected in patients taking Ayurvedic or herbal medicines and presenting with unexplained abdominal or neurological symptoms. Early diagnosis and chelation therapy may improve outcomes. Combination therapy may be tried in patients with severe poisoning.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Principal Director, Institute of Critical Care Medicine, Max Super Speciality Hospital, New Delhi, Delhi, India.
- Director, Department of Internal Medicine, Max Super Speciality Hospital, New Delhi, Delhi, India.
- Director, Institute of Critical Care Medicine, Max Super Speciality Hospital, New Delhi, Delhi, India, Corresponding Author.
- Fellow, Department of Internal Medicine, Max Super Speciality Hospital, New Delhi, Delhi, India.
Cite
APA
Singh, O., Mahajan, M., Juneja, D., & Mohammed, F. (2025). Severe Lead Poisoning Managed with Combination Chelation Therapy: Report from a Resource-limited Country. Journal of The Association of Physicians of India. https://doi.org/10.59556/japi.73.0806
Vancouver
Singh O, Mahajan M, Juneja D, Mohammed F. Severe Lead Poisoning Managed with Combination Chelation Therapy: Report from a Resource-limited Country. Journal of The Association of Physicians of India. 2025. doi:10.59556/japi.73.0806
BibTeX
@article{Singh2025,
author = {Singh, Omender and Mahajan, Monica and Juneja, Deven and Mohammed, Faizal},
title = {Severe Lead Poisoning Managed with Combination Chelation Therapy: Report from a Resource-limited Country},
journal = {Journal of The Association of Physicians of India},
year = {2025},
doi = {10.59556/japi.73.0806}
}
EUVIMED